Get the Stockscreener App
97.52
0.20%
-0.20
After Hours:
97.72
0.20
+0.21%
Boston Scientific Corp stock is traded at $97.52, with a volume of 8.13M.
It is down -0.20% in the last 24 hours and down -1.40% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$97.72
Open:
$98.05
24h Volume:
8.13M
Relative Volume:
0.86
Market Cap:
$144.57B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
52.16
EPS:
1.8696
Net Cash Flow:
$3.82B
1W Performance:
-4.00%
1M Performance:
-1.40%
6M Performance:
-5.16%
1Y Performance:
+7.72%
1-Day Range:
$97.02
$98.69
1-Week Range:
$97.02
$101.91
52-Week Range:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
97.52 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
125.08 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
364.02 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.19 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific Corporation $BSX is Bollard Group LLC's Largest Position - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Baird Financial Group Inc. - MarketBeat
Boston Sci brings next-generation Rezūm EVO Console to the UK - BioWorld MedTech
Has Boston Scientific’s Strong Runway in Minimally Invasive Therapies Stretched Its Valuation? - Yahoo! Finance Canada
Boston Scientific gets European nod for Farapoint catheter - MassDevice
Sinuscope Market Forecast Report 2032 | Olympus Corporation, - openPR.com
What valuation ratios show for Boston Scientific Corporation stockWatch List & High Accuracy Swing Entry Alerts - Newser
Why Boston Scientific Corporation stock remains on buy lists2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets - ts2.tech
Boston Scientific put volume heavy and directionally bearish - TipRanks
Quantbot Technologies LP Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - Yahoo Finance
Groupe la Francaise Purchases 297,049 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Executive Sells Over $1.7 Million in Company Stock - TradingView
Boston Scientific executive exercises options, sells 17,313 shares | BSX SEC FilingForm 4 - Stock Titan
M&A Strategy Strengthens Boston Scientific's Growth Prospects - Yahoo Finance
Fisher Asset Management LLC Acquires 939,834 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Arrowstreet Capital Limited Partnership - MarketBeat
Boston Sci's Farapoint secures CE mark - BioWorld MedTech
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
[144] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
This investor loves Boston Scientific - Cantech Letter
Boston Scientific Corporation $BSX Stock Holdings Increased by West Family Investments Inc. - MarketBeat
Boston Scientific Corp (BSX.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will Boston Scientific Corporation stock outperform tech sector in 2025Quarterly Trade Summary & Short-Term High Return Strategies - BỘ NỘI VỤ
New York State Common Retirement Fund Sells 20,594 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Mackenzie Financial Corp - MarketBeat
What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism - Yahoo Finance
How buybacks impact Boston Scientific Corporation stock value2025 Market Sentiment & Real-Time Volume Analysis - BỘ NỘI VỤ
Boston Scientific Corporation $BSX Shares Acquired by CreativeOne Wealth LLC - MarketBeat
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Finviz
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Boston Scientific Corporation $BSX Shares Sold by Korea Investment CORP - MarketBeat
Is Boston Scientific Stock Underperforming the Nasdaq? - Barchart.com
Why this money manager is buying Boston Scientific and trimming BlackRock - The Globe and Mail
Choreo LLC Buys 3,211 Shares of Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Rep. Lisa C. McClain Buys Boston Scientific Corporation (NYSE:BSX) Stock - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific's Margins Strengthen in Q3: What's Driving It? - Yahoo Finance
Boston Scientific (NYSE:BSX) Trading Volume Rises After Sector-Focused Report - Kalkine Media
Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & SuppliesDiversified Segment - Yahoo Finance
BOSTON SCIENTIFIC CORP. COMMON STOCKRo Khanna Congressional Trade on Oct. 07, 2025 - Quiver Quantitative
Boston Scientific Corp. stock rises Monday, still underperforms market - MarketWatch
Boston Scientific (BSX): Evaluating Valuation as Investors Weigh Growth and Competitive Position - Yahoo Finance
Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Analysts project durable growth with many near-term catalysts for Boston Scientific - MassDevice
BTIG Reiterates Boston Scientific (BSX) Buy Recommendation - Nasdaq
Internal Neuromodulation Devices Market Poised to Exceed USD 44.57 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Can Boston Scientific Corporation stock sustain institutional flowsMarket Activity Report & AI Driven Stock Reports - newser.com
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):